Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06398392Phase 1Completed
Phase 1, open-label, single-arm trial of [18F]PBR111. Primary endpoint: Measurement of radiation dosimetry and biodistribution of [18F]PBR111 at 6 months. Started Jun 2024; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06398392.